109 related articles for article (PubMed ID: 15023838)
1. Identification of tyrosine kinases overexpressed in head and neck cancer.
Lin HS; Berry GJ; Fee WE; Terris DJ; Sun Z
Arch Otolaryngol Head Neck Surg; 2004 Mar; 130(3):311-6. PubMed ID: 15023838
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Chan G; Boyle JO; Yang EK; Zhang F; Sacks PG; Shah JP; Edelstein D; Soslow RA; Koki AT; Woerner BM; Masferrer JL; Dannenberg AJ
Cancer Res; 1999 Mar; 59(5):991-4. PubMed ID: 10070952
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
Camacho M; León X; Fernández-Figueras MT; Quer M; Vila L
Head Neck; 2008 Sep; 30(9):1175-81. PubMed ID: 18642283
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
7. Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific polymerase chain reaction and parallel denaturing gradient gel electrophoresis.
Wang ZY; Zhang Q; Wilson J; Ratajczak MZ; Wasik MA
J Mol Diagn; 2003 May; 5(2):113-20. PubMed ID: 12707376
[TBL] [Abstract][Full Text] [Related]
8. Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.
Cohen EG; Almahmeed T; Du B; Golijanin D; Boyle JO; Soslow RA; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2003 Aug; 9(9):3425-30. PubMed ID: 12960132
[TBL] [Abstract][Full Text] [Related]
9. Molecular assay to detect metastatic head and neck squamous cell carcinoma.
Becker MT; Shores CG; Yu KK; Yarbrough WG
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):21-7. PubMed ID: 14732763
[TBL] [Abstract][Full Text] [Related]
10. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
11. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells.
Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G
Head Neck; 2004 Jun; 26(6):494-503. PubMed ID: 15162350
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
Son MY; Kim J; Han HW; Woo SM; Cho YS; Kang YK; Han YM
Reproduction; 2008 Oct; 136(4):423-32. PubMed ID: 18583472
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC.
Schultz JD; Rotunno S; Erben P; Sommer JU; Anders C; Stern-Straeter J; Hofheinz RD; Hörmann K; Sauter A
Oncol Rep; 2011 Apr; 25(4):1145-51. PubMed ID: 21249321
[TBL] [Abstract][Full Text] [Related]
17. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
Malhotra PS; Malekfzali A; Bonner RF; Juhn S; Van Waes C; Chen Z
Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.
Yarbrough WG; Whigham A; Brown B; Roach M; Slebos R
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S98-101. PubMed ID: 17848307
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
Sesterhenn AM; Mandic R; Dünne AA; Werner JA
Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
[TBL] [Abstract][Full Text] [Related]
20. A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Puttamallesh VN; Jain AP; Pinto SM; Balaji SA; Chavan S; Sahasrabuddhe NA; Mathur PP; Kumar MM; Prasad TS; Santosh V; Sukumar G; Califano JA; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
Sci Rep; 2016 Oct; 6():36132. PubMed ID: 27796319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
